Skip to main content
Top
Published in: Surgical Endoscopy 1/2013

01-01-2013

Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model

Authors: Kyle J. Thompson, Ryan Z. Swan, David A. Iannitti, Iain H. McKillop, David Sindram

Published in: Surgical Endoscopy | Issue 1/2013

Login to get access

Abstract

Background

Hepatocellular carcinoma (HCC) is a rapidly increasing cancer whose known risk factors are chronic ethanol abuse, viral hepatitis infection, and aflatoxin exposure. Obesity, an emerging HCC risk factor, is reaching epidemic proportions in developed nations. This study investigated the effects of diet-induced obesity (DIO) and chronic ethanol consumption on HCC progression in mice in vivo.

Methods

In this study, C57BL/6 DIO mice and lean litter mates were maintained on a 60 % (high-fat diet [HFD]) diet or a 10 % (control diet [CD]) kcal % fat diet for 7 weeks before they were weaned to 10/20 % ([v/v], alternating days) ethanol in drinking water (EtOH) or maintenance on drinking water (H2O) alone. Hepatic tumor formation was initiated by intrahepatic Hepa1-6 cell (6 × 106 cells) inoculation 6 weeks later via the mesenteric vein.

Results

The animals receiving the HFD showed decreased tumor incidence and area of hepatic foci versus the CD animals maintained on H2O alone. The action of EtOH suppressed tumor incidence further in both the CD and the HFD mice. Serologic analysis showed no significant differences in liver enzymes among the groups. Protein analysis demonstrated increased P450 2E1 (CYP2E1) in the groups maintained on EtOH, an effect exacerbated by HFD. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis demonstrated increased tumor necrosis factor-alpha (TNF-α) expression in HFD HCC mice (H2O and EtOH) concomitant with decreased transforming growth factor-beta (TGF-β) expression.

Conclusions

Although obesity and EtOH consumption are known risk factors for HCC initiation and development, the data in this study suggest that these factors impair progression of established tumors within the liver.
Literature
1.
go back to reference McKillop IH, Moran DM, Jin X, Koniaris LG (2006) Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 136:125–135CrossRefPubMed McKillop IH, Moran DM, Jin X, Koniaris LG (2006) Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 136:125–135CrossRefPubMed
2.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
3.
go back to reference Bosch FX, Ribes J, Cleries R, Diaz M (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191–211 vCrossRefPubMed Bosch FX, Ribes J, Cleries R, Diaz M (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191–211 vCrossRefPubMed
4.
go back to reference McKillop IH, Schrum LW (2009) Role of alcohol in liver carcinogenesis. Semin Liver Dis 29:222–232CrossRefPubMed McKillop IH, Schrum LW (2009) Role of alcohol in liver carcinogenesis. Semin Liver Dis 29:222–232CrossRefPubMed
5.
go back to reference Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefPubMed Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefPubMed
6.
go back to reference Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomark Prev 16:2533–2547CrossRef Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomark Prev 16:2533–2547CrossRef
7.
go back to reference Kant P, Hull MA (2011) Excess body weight and obesity: the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 8:224–238CrossRefPubMed Kant P, Hull MA (2011) Excess body weight and obesity: the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 8:224–238CrossRefPubMed
8.
go back to reference Bracci PM (2012) Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog 51:53–63CrossRefPubMed Bracci PM (2012) Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog 51:53–63CrossRefPubMed
9.
go back to reference Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638CrossRefPubMed Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638CrossRefPubMed
10.
go back to reference Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE (2012) Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology 55:476–482 Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE (2012) Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology 55:476–482
11.
go back to reference Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M (2011) Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140:1071–1083CrossRefPubMed Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M (2011) Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140:1071–1083CrossRefPubMed
12.
go back to reference Chiang DJ, Pritchard MT, Nagy LE (2011) Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 300:G697–G702CrossRefPubMed Chiang DJ, Pritchard MT, Nagy LE (2011) Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 300:G697–G702CrossRefPubMed
13.
go back to reference Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140:197–208CrossRefPubMed Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140:197–208CrossRefPubMed
14.
go back to reference Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517–544PubMed Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517–544PubMed
15.
go back to reference Crabb DW, Liangpunsakul S (2007) Acetaldehyde-generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1, and catalase, and speculations on the role of other enzymes and processes. Novartis Found Symp 285:4–16 discussion 16–22, 198–199CrossRefPubMed Crabb DW, Liangpunsakul S (2007) Acetaldehyde-generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1, and catalase, and speculations on the role of other enzymes and processes. Novartis Found Symp 285:4–16 discussion 16–22, 198–199CrossRefPubMed
17.
go back to reference Brandon-Warner E, Walling TL, Schrum LW, McKillop IH (2012) Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 36:641–653CrossRefPubMed Brandon-Warner E, Walling TL, Schrum LW, McKillop IH (2012) Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 36:641–653CrossRefPubMed
18.
go back to reference Kroger A, Ortmann D, Krohne TU, Mohr L, Blum HE, Hauser H, Geissler M (2001) Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice. Cancer Res 61:2609–2617PubMed Kroger A, Ortmann D, Krohne TU, Mohr L, Blum HE, Hauser H, Geissler M (2001) Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice. Cancer Res 61:2609–2617PubMed
19.
go back to reference Thompson KJ, Lakner AM, Cross BW, Tsukada S, Rippe RA, McKillop IH, Schrum LW (2011) S-adenosyl-l-methionine inhibits collagen secretion in hepatic stellate cells via increased ubiquitination. Liver Int 31:891–901CrossRefPubMed Thompson KJ, Lakner AM, Cross BW, Tsukada S, Rippe RA, McKillop IH, Schrum LW (2011) S-adenosyl-l-methionine inhibits collagen secretion in hepatic stellate cells via increased ubiquitination. Liver Int 31:891–901CrossRefPubMed
20.
go back to reference Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH (2010) Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 291:120–129CrossRefPubMed Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH (2010) Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 291:120–129CrossRefPubMed
21.
go back to reference Tian M, Schiemann WP (2009) The TGF-beta paradox in human cancer: an update. Future Oncol 5:259–271CrossRefPubMed Tian M, Schiemann WP (2009) The TGF-beta paradox in human cancer: an update. Future Oncol 5:259–271CrossRefPubMed
22.
go back to reference Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T (1993) IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808–1810CrossRefPubMed Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T (1993) IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808–1810CrossRefPubMed
23.
go back to reference Zamarron BF, Chen W (2011) Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 7:651–658CrossRefPubMed Zamarron BF, Chen W (2011) Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 7:651–658CrossRefPubMed
24.
go back to reference Qiu FB, Wu LQ, Lu Y, Zhang S, Zhang BY (2007) Predominant expression of Th1-type cytokines in primary hepatic cancer and adjacent liver tissues. Hepatobiliary Pancreat Dis Int 6:63–66PubMed Qiu FB, Wu LQ, Lu Y, Zhang S, Zhang BY (2007) Predominant expression of Th1-type cytokines in primary hepatic cancer and adjacent liver tissues. Hepatobiliary Pancreat Dis Int 6:63–66PubMed
25.
go back to reference Qi K, Qiu H, Sun D, Minuk GY, Lizardo M, Rutherford J, Orr FW (2004) Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice. Hepatology 40:1144–1150CrossRefPubMed Qi K, Qiu H, Sun D, Minuk GY, Lizardo M, Rutherford J, Orr FW (2004) Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice. Hepatology 40:1144–1150CrossRefPubMed
26.
go back to reference Edel G (1988) Mechanism of liver-specific metastatic tumor spread in a murine tumor model. J Cancer Res Clin Oncol 114:47–58CrossRefPubMed Edel G (1988) Mechanism of liver-specific metastatic tumor spread in a murine tumor model. J Cancer Res Clin Oncol 114:47–58CrossRefPubMed
27.
go back to reference Hayashi S, Yokoyama I, Namii Y, Emi N, Uchida K, Takagi H (1999) Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer. Cancer Gene Ther 6:380–384CrossRefPubMed Hayashi S, Yokoyama I, Namii Y, Emi N, Uchida K, Takagi H (1999) Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer. Cancer Gene Ther 6:380–384CrossRefPubMed
28.
go back to reference Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD (2009) Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int J Cancer 124:540–546CrossRefPubMed Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD (2009) Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int J Cancer 124:540–546CrossRefPubMed
29.
go back to reference Ashkenazi A (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420–430CrossRefPubMed Ashkenazi A (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420–430CrossRefPubMed
30.
go back to reference Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI (2010) Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 49:1406–1416CrossRefPubMed Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI (2010) Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 49:1406–1416CrossRefPubMed
31.
go back to reference Kushiro K, Nunez NP (2012) Ethanol inhibits B16-BL6 melanoma metastasis and cell phenotypes associated with metastasis. In Vivo 26:47–58PubMed Kushiro K, Nunez NP (2012) Ethanol inhibits B16-BL6 melanoma metastasis and cell phenotypes associated with metastasis. In Vivo 26:47–58PubMed
32.
go back to reference Spitzer JH, Nunez NP, Meadows SA, Gallucci RM, Blank SE, Meadows GG (2000) The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice. Alcohol Clin Exp Res 24:837–844CrossRefPubMed Spitzer JH, Nunez NP, Meadows SA, Gallucci RM, Blank SE, Meadows GG (2000) The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice. Alcohol Clin Exp Res 24:837–844CrossRefPubMed
Metadata
Title
Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model
Authors
Kyle J. Thompson
Ryan Z. Swan
David A. Iannitti
Iain H. McKillop
David Sindram
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 1/2013
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-012-2429-7

Other articles of this Issue 1/2013

Surgical Endoscopy 1/2013 Go to the issue